KRAS and neoplasm: Under this metabolic stress, SW48+/G12D and SW48+/G12V cells notably exhibited increased resilience and enhanced viability in low glucose/high glutamine environments (Fig. 2), a condition reported, for example, in some KRAS-driven tumour models (Sullivan et al, 2019).